{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "T",
          "position": "53"
        },
        "variant_string_id": "SNCA A53T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Increased levels of wild-type (WT) α-synuclein (α-syn) and mutant A53T a-syn are associated with Parkinson's disease (PD), a disease linked to abnormal mitochondrial function.",
          "judgment": "Yes",
          "reasoning": "The paper establishes that increased alpha-synuclein levels, particularly with the A53T mutation, are linked to Parkinson's disease and related to mitochondrial dysfunction, providing a clear disease mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "This study compared mitochondria prepared from differentiated SH-SY5Y cells overexpressing WT or A53T α-syn with control cells, using 2-D difference in-gel electrophoresis. Statistical analysis was carried out primarily using ANOVA (p < 0.01; Host:WT:A53T) and subsequently using independent t tests (host vs WT, host vs A53T).",
          "judgment": "Yes",
          "reasoning": "The study uses proteomic profiling of mitochondria (2-D DIGE) to evaluate changes in protein expression related to alpha-synuclein overexpression. This general class of assay (proteomic profiling in cellular models of PD) is appropriate for investigating the molecular mechanisms of PD and mitochondrial dysfunction.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "This study compared mitochondria prepared from differentiated SH-SY5Y cells overexpressing WT or A53T α-syn with control cells... Statistical analysis was carried out primarily using ANOVA (p < 0.01; Host:WT:A53T) and subsequently using independent t tests (host vs WT, host vs A53T). ...4 replicates each of control, A53T and WT groups in the pH 4-7 range and 3 replicates from each of the same three groups in the pH 6-11 range.",
          "judgment": "Yes",
          "reasoning": "The experiment includes a control group (host cells) and multiple replicates (n=3 or 4) for each experimental condition.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "N/A - The paper does not mention the use of any known pathogenic or benign variants as controls.",
          "judgment": "No",
          "reasoning": "The study does not include any known pathogenic or benign variants as controls.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting."
        },
        {
          "step_name": "Sub-step 4a: Statistical Analyses",
          "extracted_paper_info": "Statistical analysis was carried out primarily using ANOVA (p < 0.01; Host:WT:A53T) and subsequently using independent t tests (host vs WT, host vs A53T). Of the protein spots found to be differentially expressed (n = 71; p < 0.01, >1.8/<-1.8 fold change), 63 proteins were identified by LC-MS/MS",
          "judgment": "No",
          "reasoning": "The study performed statistical analyses (ANOVA, t-tests) and identified differentially expressed proteins based on p-values and fold change. However, the analyses are not used to calculate an OddsPath value or a similar quantitative measure of pathogenicity for the A53T variant itself.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "N/A - The paper does not include benign or pathogenic control variants.",
          "judgment": "N/A",
          "reasoning": "Since the study does not utilize known benign or pathogenic variants as controls, we cannot count the number of such controls.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The proteomic profiling assay demonstrates that the SNCA A53T variant affects the mitochondrial proteome in SH-SY5Y cells, supporting a role in PD pathogenesis. Since there were basic controls and replicates but no variant controls or OddsPath calculation, the final strength is PS3_supporting."
    }
  ]
}
